Revolutionizing pathology. reducing medical errors. lowering cost.

Applikate was founded by pioneers in transforming histology

A quarter of an hour, twenty minutes, passed away, and Fanny was still thinking of Edmund, Miss Crawford, and herself, without interruption from any one. She began to be surprised at being left so long, and to listen with an anxious desire of hearing their steps and their voices again. She listened, and at length she heard; she heard voices and feet approaching; but she had just satisfied herself that it was not those she wanted, when Miss Bertram, Mr. Rushworth, and Mr. Crawford issued from the same path which she had trod herself, and were before her.

“Miss Price all alone” and “My dear Fanny, how comes this?” were the first salutations. She told her story. “Poor dear Fanny,” cried her cousin, “how ill you have been used by them! You had better have staid with us.”

Then seating herself with a gentleman on each side, she resumed the conversation which had engaged them before, and discussed the possibility of improvements with much animation. Nothing was fixed on; but Henry Crawford was full of ideas and projects, and, generally speaking, whatever he proposed was immediately approved, first by her, and then by Mr. Rushworth, whose principal business seemed to be to hear the others, and who scarcely risked an original thought of his own beyond a wish that they had seen his friend Smith’s place.

After some minutes spent in this way, Miss Bertram, observing the iron gate, expressed a wish of passing through it into the park, that their views and their plans might be more comprehensive. It was the very thing of all others to be wished, it was the best, it was the only way of proceeding with any advantage, in Henry Crawford’s opinion; and he directly saw a knoll not half a mile off, which would give them exactly the requisite command of the house. Go therefore they must to that knoll, and through that gate; but the gate was locked. Mr. Rushworth wished he had brought the key; he had been very near thinking whether he should not bring the key; he was determined he would never come without the key again; but still this did not remove the present evil. They could not get through; and as Miss Bertram’s inclination for so doing did by no means lessen, it ended in Mr. Rushworth’s declaring outright that he would go and fetch the key. He set off accordingly.

“It is undoubtedly the best thing we can do now, as we are so far from the house already,” said Mr. Crawford, when he was gone.

“Yes, there is nothing else to be done. But now, sincerely, do not you find the place altogether worse than you expected?”

“No, indeed, far otherwise. I find it better, grander, more complete in its style, though that style may not be the best. And to tell you the truth,” speaking rather lower, “I do not think that _I_ shall ever see Sotherton again with so much pleasure as I do now. Another summer will hardly improve it to me.”

After a moment’s embarrassment the lady replied, “You are too much a man of the world not to see with the eyes of the world. If other people think Sotherton improved, I have no doubt that you will.”

“I am afraid I am not quite so much the man of the world as might be good for me in some points. My feelings are not quite so evanescent, nor my memory of the past under such easy dominion as one finds to be the case with men of the world.”

This was followed by a short silence. Miss Bertram began again. “You seemed to enjoy your drive here very much this morning. I was glad to see you so well entertained. You and Julia were laughing the whole way.”

“Were we? Yes, I believe we were; but I have not the least recollection at what. Oh! I believe I was relating to her some ridiculous stories of an old Irish groom of my uncle’s. Your sister loves to laugh.”

“You think her more light-hearted than I am?”

Scroll to Top
 
Natural Language Processing with Deep Learning
 
Machine Learning

William Tunstall-Pedoe

Investor, Technology Expert, and Entrepreneur
William Tunstall-Pedoe is an entrepreneur who founded the British voice-assistant company Evi, which was purchased by Amazon in 2012 and became the basis for Amazon Alex and Echo devices. William mentors and invests in innovative startups and has holdings in more than 70 companies.
 
Virginia Commonwealth University
 
Yale University

John Turner

Medical Expert, Pathologist, and Business Advisor
John Turner trained as resident and fellow at Duke University University Medical Center receiving his boards in Anatomic, Clinical, and Dermatopathology. A practicing pathologist, he is the HCA/ForwardPathology Solutions Capital Division Medical Director and Chief of the Medical Staff for CJW Medical Center. Dr. Turner is a medical advisor to Applikate.
 
University of Cambridge

Andrew Nutter

Investor, Technology Expert, and Entrepreneur
Andrew is the co-founder of Gama, a deep space exploration company. He is an investor in over 60 companies across a range of industries, from synthetic biology to nuclear fusion. Previously, Andrew built Westwing, a publicly listed home and living ecommerce business across Europe, Russia, and Brazil. He is a veteran of Balderton Capital and McKinsey & Company.

 
Virginia Commonwealth University School of Medicine
 
Randolph-Macon College

Dick Hamrick

Investor, Physician, Medical Expert, and Business Advisor
Dick Hamrick is a pulmonary/critical care physician with a long history of diverse and broad leadership positions including as a Divisional Chief Medical Officer for HCA. Dr. Hamrick serves as a healthcare consultant and as an advisor/board member for Applikate and several early stage companies.

Ron Bridges

Investor, Physician, Medical Expert, and Professor
Ron Bridges is a Professor of Medicine and Gastroenterologist at the Cumming School of Medicine, University of Calgary. He has held several senior leadership roles, authored more than 40 papers and is actively involved as a mentor at the Creative Destruction Lab. Ron is an angel investor with an interest in medical devices and health care innovations.

Julie Cook

Investor, Information Technology Expert, and Business Advisor

Julie is CIO of Ensemble IP and an investor in Applikate. She has extensive experience managing software development, software implementation, data science, and IT security projects. Previously, she led a Health Information Management (HIM) department; and provided consulting, implementation, and training services as part of the delivery of HIM software to hospitals and clinics worldwide.

Donald Plewes

Investor, Professor, and Medical Device Expert
Donald Plewes is Professor Emeritus from the Department of Medical Biophysics of the University of Toronto. His career has been devoted to research in the physics of medical imaging and has included x-ray imaging, computed tomography, ultrasound, and magnetic resonance imaging with clinical applications. His research proceeds from bench science and clinical trials; and has led to the successful commercialization of advanced technologies for breast screening and magnetic resonance imaging.

Dr. Plewes has published widely, holds numerous patents, and is an investor in and expert advisor to Applikate Technologies.
MSc, Aviation Systems
 
University of Waterloo
 
Royal Military College of Canada/Collège militaire royal du Canada
 
Royal Roads University

Chris Hadfield

Investor, Astronaut, and Technology Expert
Chris Hadfield is an engineer, military fighter/test pilot and thrice-flown astronaut, having done two spacewalks and commanded the International Space Station. He is an advisor/director for multiple high-tech companies, and leads the Space stream at the Creative Destruction Lab tech incubator. Chris is a four-time internationally best-selling author, a professor at U Waterloo and online at Masterclass, and has created/hosted TV series with both BBC and National Geographic. Chris is an investor in Applikate Technologies and serves as an advisor to the company.

 
Caltech

Eben Olson, Ph.D.

Lead Engineer
Eben Olson, Ph.D. is an Associate Research Scientist in the Department of Laboratory Medicine at Yale University, where he has been a member since 2013. His graduate degree is in Applied Physics with a focus on Biomedical Optics. Eben has been performing research involving development of software tools and methods for processing, visualization, and analysis of large image datasets. He is a core contributor to neural network framework modules in Python and has competed successfully in a number of data science competitions on kaggle.com and drivendata.org. He has extensive experience in electronics, machining, CAD, and optical design, having constructed several advanced multiphoton microscopes including design of control boards, optical element assembly, and embedded control software as well as having written Applikate’s StackStreamer software. In part through management of the engineering and clinical consultants. His primary responsibilities include engineering development, software conversion efforts, technical assessments and performance monitoring, component fabrication, hardware and software systems installations during clinical study, and directing engineering support during data acquisition.

Cohort 4 Full Time, Certificate 2019

 
Massachusetts Institute of Technology

 
William & Mary – Raymond A. Mason School of Business

 
William & Mary

David Hunt, MBA

Executive Chairman
Dave Hunt is Executive Chairman of Applikate. He is also the CEO and majority shareholder at Ensemble IP. Previously, he owned and led Landon IP, a large professional patent search and analytics company with operating offices in the United States, Japan, United Kingdom, Germany, India, and China. He is an early-stage investor in several medical device and AI-focused companies and led the Seed Series round for Applikate Technologies. He leads the business functions of Applikate and chairs the Board of Directors. He is a graduate of the College of William & Mary (B.A., ‘87, M.B.A, ‘93) and the Harvard Business Analytics Program (’19). Dave speaks English and Japanese.
Caltech
 
University of Rochester

Michael Levene, Ph.D.

Founder, Co-CEO
Michael Levene pioneered the combination of multiphoton microscopy, the optical clearing of tissue and its application to pathology. He served on the faculty of Yale University from 2004 to 2014, after which he co-founded Applikate. Michael holds 20 granted U.S. Patents, authored 32 publications, and raised more than $6.3 million in research support between 2007 and the present.
Prior to joining Yale,  Michael was a Research Associate in Applied and Engineering Physics at Cornell University, where he worked with Prof. Watt Webb and co-invented zero-mode waveguides for single molecule DNA sequencing, the technological foundation of Pacific Biosciences, Inc.
Yale University School of Medicine
 
 

Richard Torres, M.D.

Founder, Co-CEO
Rick Torres is a pathologist and biomedical engineer with expertise in medical laboratory instrumentation. He is board certified in Clinical and Anatomic Pathology and has worked as an independent consultant on commercial medical diagnostic devices. His clinical interests include flow cytometry, pathology informatics, and next generation sequencing for hematologic malignancies, having served as medical director of clinical chemistry, hematology, immunology, and flow cytometry laboratories. Rick Torres co-invented the novel histology techniques and devices developed by Applikate, served on the faculty of Yale University, co-founded the company, serves as Co-CEO, and holds several seminal patents. He maintains an adjunct appointment at Yale where he continues to perform part-time clinical interpretative work.